Skip to main content

Table 4 Physical characteristics and current medications of the Type 2 Diabetes Mellitus (T2DM) and Control groups

From: Removal from the plasma of the free and esterified forms of cholesterol and transfer of lipids to HDL in type 2 diabetes mellitus patients

 

T2DM

Control

P

N

15

11

 

Age (years)

58.9 ± 4.8

54.6 ± 5.5

0.06

Sex (M/F)

7/8

5/6

1.00

Weight (kg)

82.1 ± 11.7

74.9 ± 7.3

0.08

BMI (kg/m2)

31.9 ± 4.6

27.1 ± 2.4

<0.01

Waist Circumference (cm)

104.9 ± 9.8

94.2 ± 7.3

<0.01

Arterial Hypertension

10

5

0.43

Familial history CVD

5

5

0.69

Current smoking

3

2

0.22

Current medications

   

 Metformin

15

-

-

 Sulfonylurea

8

-

-

 Insulin

4

-

-

 ACEi

9

4

0.39

 ARB

1

1

1.00

 Ca channel blockers

3

2

0.49

 Thiazides

2

1

1.00

 AAS

4

0

0.10

  1. Data are means ± SD. CVD, cardiovascular disease. ACEi, angiotensin-converting enzyme inhibitor. ARB, angiotensin II receptor blocker. Ca, calcium.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X